$ベンティックス・バイオサイエンシズ(VTYX.US)$$ニオ(NIO.US)$$イーライリリー(LLY.US)$$Structure Therapeutics Inc(GPCR.US)$ Obesity Drug - Update & Battle for Skinny SubQ- $VKTX ph2 results puts the company in driver's seat after showing impressive results both in efficacy and safety $VKTX has shown twice as much weight loss in 13 weeks what $LLY has done in 12 weeks and what $NVO has shown in 40 plus weeks In safety, VKTX shown its superiority too vs LLY and NVO For comparison...
Morning Movers Gapping up $オラクル(ORCL.US)$The information technology company saw its stock climb 13.3% due to strong per-share earnings, with adjusted earnings per share of $1.41 surpassing the consensus estimate. $コールズ(KSS.US)$The retailer's shares increased by 2.2% after reporting earnings and revenue that exceeded expectations for the fourth quarter. $コインベース(COIN.US)$The cryptocurrency trading platform's shares...
The stock market started off on a good note and really picked up speed at 10 pm (GST +8) after a very positive ISM Manufacturing report, which showed just the right balance of growth without too much inflation. On top of that, the tech sector, which was already doing well, received an extra boost from a highly praised report by DELL. By the end of the trading session, stocks closed near their highest points for the day, with more stocks reaching new highs on both maj...
ベンティックス・バイオサイエンシズに関するコメント
Who wins the Skinny pill VKTX!!
Obesity Drug - Update & Battle for Skinny
SubQ- $VKTX ph2 results puts the company in driver's seat after showing impressive results both in efficacy and safety
$VKTX has shown twice as much weight loss in 13 weeks what $LLY has done in 12 weeks and what $NVO has shown in 40 plus weeks
In safety, VKTX shown its superiority too vs LLY and NVO
For comparison...
コラムToday's Morning Movers and Top Ratings: ORCL, CVNA, MSTR, AAL and More
Gapping up
$オラクル(ORCL.US)$ The information technology company saw its stock climb 13.3% due to strong per-share earnings, with adjusted earnings per share of $1.41 surpassing the consensus estimate.
$コールズ(KSS.US)$ The retailer's shares increased by 2.2% after reporting earnings and revenue that exceeded expectations for the fourth quarter.
$コインベース(COIN.US)$ The cryptocurrency trading platform's shares...
Ventyx Biosciences Announces $100M Private Placement Of Common Stock
$VTYX
Market Summary 1st March 2024
Ventyx confirms FDA approval
Ventyx to receive FDA approval this week
Newsss- may determine make or breakk
get up to 7 pleasseeee!
まだコメントはありません